# Genetic & Function Analysis

## I. RNA & Epigenetics

### **1. Genetics & Post-GWAS**

* ✅ **2024 Nature Genetics** - Genetic mapping across autoimmune diseases reveals shared associations and mechanisms
* **2024 Nature Communications** - Integrating single cell expression quantitative trait loci summary statistics to understand complex trait risk genes
* **2022 Nature genetics** - Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data
* **2022 Cancer Discovery** - Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles Somatic Mutations and 3D Genomic Architecture
* **2019 Nature Communications** - SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell speciﬁc enhancer that controls disease-critical microRNA expression

### 2. RNA & Function Analysis

* **2024 Cell Reports Medicine** - Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE

## II. RNA editing and splicing

### 1. Genetics & Post-GWAS

* **2024 Nature Communications** - Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms
* ✅ [**2022 Nature**](https://pubmed.ncbi.nlm.nih.gov/35922514/) - RNA editing underlies genetic risk of common inflammatory diseases
* **2022 Nature Genetics** - Genetic control of RNA splicing and its distinct role in complex trait variation
* ✅  _**2020 Nature**_ - PCAWG - Genomic basis for RNA alterations in cancer
* **2020 Genome Biology** - Human A-to-I RNA editing SNP loci are enriched in GWAS signals for autoimmune diseases and under balancing selection
* [**2019 Nature Genetics**](https://www.nature.com/articles/s41588-021-00864-5) - An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability

### 2. Functional Regulation

* **2017 Genome Research** - Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. &#x20;
* **2015 Cancer cell** - The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers&#x20;

## III. RNA modification

### 1. Genetics & Post-GWAS

* \[m6a-qtl in 129 tissue m6a-seq] **2021 Nature Genetics** - Genetic drivers of m 6 A methylation in human brain, lung, heart and muscle
* ✅ \[m6a-qtl in 60 celllines] **2020 Nature Genetics** - Genetic analyses support the contribution of mRNA N 6 -methyladenosine (m 6 A) modification to human disease heritability

### 2. Functional Regulation

* ✅ \[m6a regulators in public 9804 samples] **2021 Molecular Cancer** - Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types
* \[rna mod. regulators in 1697 public crc samples] **2021 Molecular Cancer** - Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
* \[rna mod. regulators in 13358 public tissue rna-seq] **2020 Genome Biology** - Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures

